Missing/wrong data?
Log in to edit
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study
scientific article published on 01 September 2018
Author/s
author: Franz Josef Gassner, Nadja Zaborsky, Tanja N Hartmann, Lisa Pleyer, Richard Greil
Work details
Publication date
September 1, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.